p53 N‑terminal binding and stabilisation by PIAS3 inhibits MDM2‑induced p53 ubiquitination and regulates cell growth

Ziyi Zhao1, Lan Wu1, Huimin Shi1

  • 1Key Laboratory of Bioresources and Ecoenvironment, Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, P.R. China.

Insights

The protein inhibitor of activated STAT3 (PIAS3) binds to the p53 protein, stabilizing it and enhancing its tumor-suppressing functions. This interaction prevents MDM2 binding, increasing p53 levels and activity.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Mouse double minute 2 homolog (MDM2) targets p53 for degradation, inhibiting its tumor-suppressive functions.
  • Understanding p53 regulation is crucial for cancer therapy.

Purpose of the Study:

  • To investigate novel interactions with p53.
  • To identify proteins that bind to the N-terminal region of p53 (amino acids 1-52).

Main Methods:

  • Stable expression of wild-type p53's N-terminal region in H1299 cells.
  • Co-immunoprecipitation and mass spectrometry to identify binding partners.
  • Overexpression of PIAS3 in A549 cells to assess p53 stability and activity.

Main Results:

  • Protein inhibitor of activated STAT3 (PIAS3) was identified as a binding partner of p53.
  • PIAS3 binds to the p53 N-terminal region (amino acids 1-52), disrupting the p53-MDM2 complex.
  • PIAS3 overexpression increased p53 half-life, reduced p53 ubiquitination, and enhanced p53-mediated transcription of p21/waf1.

Conclusions:

  • PIAS3 is a novel interactor of p53, binding to its N-terminal region.
  • The p53-PIAS3 interaction stabilizes p53 by inhibiting MDM2-mediated degradation.
  • This interaction enhances p53's tumor-suppressive transcriptional activity.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K